ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within the ENETS Center of Excellence network, harmonisation with specialist imaging societies including the Society of Nuclear Medicine, European Association of Nuclear Medicine and the International Cancer Imaging Society will be pursued.

Automated summary

ENETS aims to improve the standard of care for patients with neuroendocrine neoplasms (NEN) by providing standardized reporting guidance for diagnostic studies, including pathology, radiology, endoscopy, and molecular imaging. A reporting template for personalized therapies in molecular imaging procedures has been developed and is undergoing pilot implementation within the ENETS Center of Excellence network, with plans for harmonization with other specialist imaging societies.